Journal of Medicinal Chemistry · 2009 · 17 citations · 16 references
MedicineMedicinal ChemistryPharmacologyNeuropharmacologyPsychopharmacologyStructure-activity RelationshipsDopaminergic PharmacologyPotency OptimizationReceptor PharmacologySerotonergic PharmacologySerotonergic Signaling5-Hydroxytryptamine Receptor PharmacologyPharmacology Of Serotonergic AgentsSelectivitySerotonin AntagonistsSerotonin PharmacodynamicsSerotonin PharmacokineticsSerotonin Receptor PharmacologySerotonin Reuptake Inhibition
On the basis of the previously reported clinical candidate, SSA-426 (1), a series of related 2-piperazin-1-ylquinoline derivatives 3-16 were synthesized and evaluated as dual-acting serotonin (5-HT) reuptake inhibitors and 5-HT1A receptor antagonists. In particular, compound 7 exhibits potent functional activities at both the 5-HT transporter and 5-HT1A receptor, good selectivity over the alpha1-adrenergic and dopaminergic receptors, acceptable pharmacokinetic properties, and a favorable in vivo profile.
16
Sebastian Lazareno, N.J.M. Birdsall · British Journal of Pharmacology · 1993 · 156 citations · Full text
Medicine, Biochemistry, Pharmacology +17
Lee E. Schechter, Daniel L. Smith, Sharon Rosenzweig‐Lipson et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 130 citations · Full text
Medicine, Neuroscience, Pharmacology +17